bioAffinity Technologies, Inc. BIAF IPO will take place August, 26 on the NASDAQ exchange under the ticker BIAF.
The company is offering shares at an expected price between $6.00 and $6.25 per share with an insider lock-up period of 180 days ending on February 22, 2023.
See also: Benzinga IPO Calendar
About bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. is a privately held company incorporated in Delaware addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, and targeted cancer treatment.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
